PMC:7696151 / 76256-76362
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2248 | 0-10 | Chemical | denotes | Epirubicin | MESH:D015251 |
| 2267 | 30-43 | Disease | denotes | breast cancer | MESH:D001943 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T154 | 30-43 | Phenotype | denotes | breast cancer | http://purl.obolibrary.org/obo/HP_0003002 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T489 | 0-106 | Sentence | denotes | Epirubicin in triple-negative breast cancer therapy often lost efficacy, due to chemoresistance acquiring. |